Titre

The impact of financialisation on Global Health: Exploring the influence of investors on the AMR Puzzle Does financialisation explain why we are not producing enough antibiotics?

Auteur Nadya WELLS
Directeur /trice Prof Stephan Harbarth
Co-directeur(s) /trice(s) Prof Vinh-Kim Nguyen Prof Stephanie Dagron
Résumé de la thèse The paradox of commercial interests and lack of profit precluding both emergence of innovative "new" antibiotics and the production of long extant "old" medicine which is leading to shortages. Examining the issue through specific drug case studies from both ends of the pharmaceutical life cycle pre- and post- commercialisation.
Statut au début
Délai administratif de soutenance de thèse 2023
URL
LinkedIn
Facebook
Twitter
Xing